Support PenkeDelaware Ivy VIP Mid Cap Growth II
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CERN.NASDAQ | CERN.NASDAQ | - | - | - | - | 0.069 | 2.575 | 203.6k | - | - | ||||||||||||||
| GMAB.NASDAQ | Genmab AS | USA | Healthcare | Biotechnology | 2024-09-30 | 0.025 | 1.278 | 163.5k | $1.1m | $3.2m |
| |||||||||||||
| MSP.NYSE | MSP.NYSE | - | - | - | - | 0.058 | 0.434 | 96.5k | - | - |
Trades
Adds
Report date: 2022-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | Price Range | Price | % |
| MSP.NYSE | 4.7k | 5.2 | 0.00 | 0-0 | - | - |
Reduces
Report date: 2022-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| GMAB.NASDAQ | -15k | -6.8 | -528k | 31-38 | $19.58 | -37.6% |
Comments
How you think about this?